Detalhe da pesquisa
1.
First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors.
Cancer Immunol Immunother
; 72(7): 2443-2458, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37016126
2.
Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses.
Ann Rheum Dis
; 78(2): 228-237, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30459279
3.
Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2018 Conference Workshops.
Cytometry A
; 95(6): 598-644, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31207046
4.
A comparative study of blood cell count in four automated hematology analyzers: An evaluation of the impact of preanalytical factors.
PLoS One
; 19(5): e0301845, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38787860
5.
Flow Cytometry Method Validation Protocols.
Curr Protoc
; 3(8): e868, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37606503
6.
2022 White Paper on Recent Issues in Bioanalysis: Enzyme Assay Validation, BAV for Primary End Points, Vaccine Functional Assays, Cytometry in Tissue, LBA in Rare Matrices, Complex NAb Assays, Spectral Cytometry, Endogenous Analytes, Extracellular Vesicles Part 2 - Recommendations on Biomarkers/CDx, Flow Cytometry, Ligand-Binding Assays Development & Validation; Emerging Technologies; Critical Reagents Deep Characterization.
Bioanalysis
; 15(15): 861-903, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584363
7.
2021 White Paper on Recent Issues in Bioanalysis: ISR for Biomarkers, Liquid Biopsies, Spectral Cytometry, Inhalation/Oral & Multispecific Biotherapeutics, Accuracy/LLOQ for Flow Cytometry (Part 2 - Recommendations on Biomarkers/CDx Assays Development & Validation, Cytometry Validation & Innovation, Biotherapeutics PK LBA Regulated Bioanalysis, Critical Reagents & Positive Controls Generation).
Bioanalysis
; 14(10): 627-692, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35578974
8.
High-sensitivity flow cytometric assays: Considerations for design control and analytical validation for identification of Rare events.
Cytometry B Clin Cytom
; 100(1): 42-51, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32940947
9.
Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analyses.
Cytometry B Clin Cytom
; 100(1): 79-91, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33373096
10.
2020 White Paper on Recent Issues in Bioanalysis: BAV Guidance, CLSI H62, Biotherapeutics Stability, Parallelism Testing, CyTOF and Regulatory Feedback (Part 2A - Recommendations on Biotherapeutics Stability, PK LBA Regulated Bioanalysis, Biomarkers Assays, Cytometry Validation & Innovation Part 2B - Regulatory Agencies' Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine).
Bioanalysis
; 13(5): 295-361, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33511867
11.
Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors.
Clin Cancer Res
; 26(20): 5358-5367, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32816951
12.
Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
Cell Immunol
; 258(1): 65-71, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19410243
13.
Flow Cytometry Method Validation Protocols.
Curr Protoc Cytom
; 87(1): e53, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30418706
14.
Correction: Flow Cytometry Method Validation Protocols.
Curr Protoc
; 4(1): e988, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38270497
15.
A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity.
Sci Transl Med
; 11(489)2019 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31019027
16.
Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein.
Mol Cancer Ther
; 17(5): 1024-1038, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29545330
17.
Developmental alterations in thymocyte sensitivity are actively regulated by MHC class II expression in the thymic medulla.
J Immunol
; 176(4): 2229-37, 2006 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16455979